What is the most recent earnings date for TNXP stock?
TONIX PHARMACEUTICALS HOLDIN (TNXP) last reported earnings on 3/12/2026.
TONIX PHARMACEUTICALS HOLDIN (TNXP) Earnings History & Surprises
NASDAQ:TNXP • US8902608392
Current stock price
15.77 USD
+1.58 (+11.13%)
At close:
15.8 USD
+0.03 (+0.19%)
Pre-Market:
TNXP Earnings overview
Past quarterly earnings results for TONIX PHARMACEUTICALS HOLDIN (TNXP), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 11, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$2.63
- Revenue Estimate
- 13.209M
Last Reported
Most Recent- Release Date
- Mar 12, 2026
- Period
- Q4 / 2025
- EPS Reported
- -$3.98
- EPS Surprise
- -22.32%
- Revenue Surprise
- 83.27%
Beat Rate
Last 8 Quarters 44%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -3.98 | -3.25 | -22.32% | 59.26% | 5.39M | 2.941M | 83.27% | 108.75% |
| Q3 2025 | -3.59 | -3.66 | 1.82% | 84.39% | 3.29M | 3.162M | 4.05% | 16.58% |
| Q2 2025 | -3.86 | -3.28 | -17.71% | 99.80% | 1.998M | 2.482M | -19.50% | -9.51% |
| Q1 2025 | -2.84 | -3.29 | 13.80% | 99.51% | 2.429M | 2.601M | -6.61% | -2.14% |
| Q4 2024 | -9.77 | -394.86 | 97.53% | 99.64% | 2.582M | 3.57M | -27.68% | -31.68% |
| Q3 2024 | -23.00 | -299.20 | 92.31% | 99.61% | 2.822M | 3.145M | -10.27% | -29.26% |
| Q2 2024 | -1,928.00 | -333.88 | -477.45% | 77.52% | 2.208M | 3.57M | -38.15% | - |
| Q1 2024 | -576.00 | -1,272.96 | 54.75% | 94.46% | 2.482M | 3.876M | -35.96% | - |
| Q4 2023 | -2,752.00 | -5,363.83 | 48.69% | 75.43% | 3.779M | 3.91M | -3.35% | - |
| Q3 2023 | -5,856.00 | -4,863.36 | -20.41% | 57.57% | 3.989M | 5.916M | -32.57% | - |
| Q2 2023 | -8,576.00 | -8,992.32 | 4.63% | 64.85% | - | - | ||
| Q1 2023 | -10,400.00 | -9,894.00 | -5.11% | 67.50% | - | - | ||
| Q4 2022 | -11,200.00 | -17,544.00 | 36.16% | 75.00% | - | - | ||
| Q3 2022 | -13,800.00 | -20,808.00 | 33.68% | 56.88% | - | - | ||
| Q2 2022 | -24,400.00 | -29,478.00 | 17.23% | 45.54% | - | - | ||
| Q1 2022 | -32,000.00 | -30,466.18 | -5.03% | 28.57% | - | - | ||
| Q4 2021 | -44,800.00 | -39,168.00 | -14.38% | 30.00% | - | - | ||
| Q3 2021 | -32,000.00 | -45,696.00 | 29.97% | 44.44% | - | - | ||
| Q2 2021 | -44,800.00 | -42,432.00 | -5.58% | 69.57% | - | - | ||
| Q1 2021 | -44,800.00 | -35,904.00 | -24.78% | 76.67% | - | - | ||
| Q4 2020 | -64,000.00 | -48,960.00 | -30.72% | - | - | - | ||
| Q3 2020 | -57,600.00 | -71,808.00 | 19.79% | - | - | - | ||
| Q2 2020 | -147,200.00 | -146,880.00 | -0.22% | - | - | - | ||
| Q1 2020 | -192,000.00 | -205,632.00 | 6.63% | - | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
2
Average EPS beat (4)
-6.10%
Max EPS beat (4)
13.80%
Min EPS beat (4)
-22.32%
Revenue beat statistics
Revenue beat (4)
2
Average Revenue beat (4)
15.30%
Max Revenue beat (4)
83.27%
Min Revenue beat (4)
-19.50%
Analysis
In the last 4 quarters, TNXP has beaten EPS estimates in 2 out of 4 releases
TNXP has beaten revenue estimates in 2 out of the last 4 releases
In the last 4 quarters, TNXP reported -6.1% below the EPS estimates on average.
In the last 4 quarters, TNXP has beaten the revenue estimates by 15.3% on average.
Related analysis
TONIX PHARMACEUTICALS HOLDIN / TNXP Earnings FAQ
Did TONIX PHARMACEUTICALS HOLDIN (TNXP) beat earnings estimates last quarter?
TONIX PHARMACEUTICALS HOLDIN (TNXP) missed EPS estimates and beat revenue estimates in the most recent quarter.
How often does TONIX PHARMACEUTICALS HOLDIN (TNXP) beat earnings estimates?
In the last 4 quarters, TONIX PHARMACEUTICALS HOLDIN (TNXP) has beaten EPS estimates in 2 out of 4 releases.